Roughly 1 in 10 US internal medicine physicians report a high degree of burnout, according to a study published online.

HealthDay News — The Trump administration has canceled more than $800 million in research focused on LGBTQ health, cutting hundreds of studies on cancer, HIV and other diseases that affect sexual and ...

Levothyroxine therapy was associated with improved cardiovascular health but reduced bone health among older adults with subclinical hypothyroidism.

Hormone therapy use is linked to worse bladder health in postmenopausal women, according to a study published online.

Among patients with RA, ACPA status significantly modifies the relationship between BMI and cardiovascular risk.

The EULAR updated their recommendations for antirheumatic drug use among patients with RMDs during pregnancy and fertility treatment.

Immunological tests can differentiate proliferative from non-proliferative lupus nephritis, but anti-C1q antibodies and urinary erythrocytes have the best predictive power to dist ...

Among patients with acute LBP, use of nonpharmacologic therapy was associated with reduced risk for overdose-related hospitalizations.

The FDA has approved Selarsdi (ustekinumab-aken) as interchangeable to the reference product Stelara (ustekinumab).

Type 1 diabetes was associated with an elevated risk for osteoporotic fracture regardless of femoral neck bone mineral density.

Patients with giant cell arteritis have a greater risk for aortic complications than those with polymyalgia rheumatica.

The FDA has communicated to Stealth BioTherapeutics that it would not meet elamipretide’s PDUFA target date for the treatment of Barth syndrome.